Bone-Vascular Axis in Chronic Kidney Disease

Adv Chronic Kidney Dis. 2019 Nov;26(6):472-483. doi: 10.1053/j.ackd.2019.09.006.

Abstract

Patients with chronic kidney disease (CKD) are at increased risk of osteoporosis and vascular calcification. Bone demineralization and vascular mineralization go often hand in hand in CKD, similar to as in the general population. This contradictory association is independent of aging and is commonly referred to as the "calcification paradox" or the bone-vascular axis. Various common risk factors and mechanisms have been identified. Alternatively, calcifying vessels may release circulating factors that affect bone metabolism, while bone disease may infer conditions that favor vascular calcification. The present review focuses on emerging concepts and major mechanisms involved in the bone-vascular axis in the setting of CKD. A better understanding of these concepts and mechanisms may identify therapeutics able to target and exert beneficial effects on bone and vasculature simultaneously.

Keywords: Bone; Vascular calcification.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Animals
  • Cardiovascular Diseases / metabolism
  • Glucuronidase / metabolism*
  • Humans
  • Inflammation / metabolism
  • Klotho Proteins
  • Osteoporosis / metabolism*
  • Osteoprotegerin / metabolism*
  • Parathyroid Hormone / metabolism
  • Renal Insufficiency, Chronic / metabolism*
  • Signal Transduction
  • Vascular Calcification / metabolism*
  • Vitamin K / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Osteoprotegerin
  • Parathyroid Hormone
  • SOST protein, human
  • Vitamin K
  • Glucuronidase
  • Klotho Proteins